868211-93-2

Upstream product

• 103440-95-5 4-Ethyl-3-nitrobenzoic acid 
• 619-64-7 p-ethylbenzoic acid 
• 51885-79-1 4-ethyl-3-nitro-benzoic acid methyl ester 
• 24812-93-9 3-amino-4-ethylbenzoic acid methyl ester 
• 925-90-6 ethylmagnesium bromide 
• 849758-12-9 methyl 4-bromo-3-fluorobenzoate 
• 868211-92-1 methyl 3-fluoro-4-vinylbenzoate 
• 7486-35-3 tri-n-butyl(vinyl)tin 

Downstream Products

• 1142924-72-8 4-ethyl-3-fluorobenzoic acid 

Relevant academic research and scientific papers

Substituted amide phenol compound and its preparation method, pharmaceutical composition and use thereof

The invention discloses substituted-amide phenolic compounds, their preparation method, a pharmaceutical composition and an application thereof. The compounds have a structure as shown in the general formula I, wherein Z, L and Q are as defined in the spe

HISTONE DEMETHYLASE INHIBITORS

Provided herein are substituted pyrazolylpyridine, pyrazolylpyridazine, and pyrazolylpyrimidine derivative compounds and pharmaceutical compositions comprising said compounds. The subject compounds and compositions are useful for inhibition histone demethylase. Furthermore, the subject compounds and compositions are useful for the treatment of cancer, such as prostate cancer, breast cancer, bladder cancer, lung cancer and/or melanoma and the like.

PGD2 receptor antagonists for the treatment of inflammatory diseases

Disclosed herein are compounds represented by Structural Formula (I) and (I-A): Also disclosed is the use of such compounds for inhibiting the G-protein coupled receptor referred to as chemoattractant receptor-homologous molecule expressed on Th2, or simp